The MarketWatch News Department was not involved in the creation of this content.-- This marks the first live procedure at AAHS, as well as a first for Keenova. -- Treatment takes ...

DUBLIN, Jan. 24, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that the peer-reviewed Journal of Hand Surgery Global Open published Collagenase Clostridium Histolyticum for ...

Common activities for patients with Dupuytren's such as those at the workplace (eg, manual labor, wearing gloves) or at home (eg, washing, dressing) can be signicantly affected, posing a threat to ...

September 17, 2009 — The US Food and Drug Administration (FDA)'s Arthritis Advisory Committee voted unanimously (12 to 0) yesterday to recommend approval of collagenase clostridium histolyticum ...

Keenova Therapeutics plc announced today that a new presentation related to Dupuytren's contracture (DC) and XIAFLEX® (collagenase clostridium histolyticum, or CCH) will be shared at the American ...

Campaign builds on the momentum of Endo's disease awareness efforts. Commercial features a real patient—who was an untreated patient in a prior Endo video series—and his wife, sharing their personal ...

In the coming months you may hear about a new drug for treating cellulite, called Xiaflex. The pharmaceutical manufacturer that makes it just began clinical trials of its effects in January. I am not ...

Shares of Auxilium Pharmaceuticals Inc. climbed 17.4 percent Wednesday on news that the FDA had approved Xiaflex (collagenase Clostridium histolyticum) as the first drug in the U.S. to treat Dupuytren ...

Consensus-based study findings among expert hand surgeons indicate that XIAFLEX ® (collagenase clostridium histolyticum) has a wide-ranging application for the appropriate treatment of Dupuytren's ...

Analysis to Be Presented at the American Association for Hand Surgery Meeting DUBLIN, Jan. 13, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that a ...